Hutchin Hill Capital’s West Pharmaceutical WST Stock Holding History

Hutchin Hill Capital’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-20,900	Closed	-$1.98M	–	985
2017 Q2	$1.98M	Buy	20,900 +15,800	+310%	+$1.45M	0.07%	320
2017 Q1	$416K	Sell	5,100 -600	-11%	-$50.2K	0.01%	729
2016 Q4	$484K	Buy	+5,700	New	+$448K	0.02%	594
2014 Q1	–	Sell	-5,800	Closed	-$285K	–	737
2013 Q4	$285K	Sell	5,800 -8,000	-58%	-$374K	0.02%	445
2013 Q3	$568K	Buy	+13,800	New	+$526K	0.05%	306

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Hutchin Hill Capital's WST Position: Q3 2017 in Review

Hutchin Hill Capital sold out of West Pharmaceutical (WST) in Q3 2017, closing a stake of 20,900 shares — an estimated $1.98M sold.

Hutchin Hill Capital first reported a position in WST in Q3 2013 and held it in 5 quarters. The position peaked at $1.98M in Q2 2017. 302 funds tracked by Wall St. Rank hold WST as of Q3 2017.

Hutchin Hill Capital reported no remaining West Pharmaceutical position as of Q3 2017 after selling out during the quarter.
Hutchin Hill Capital sold 20,900 West Pharmaceutical shares in Q3 2017, an estimated $1.98M.
Hutchin Hill Capital first reported a position in West Pharmaceutical in Q3 2013 and held it in 5 quarters.
Hutchin Hill Capital's West Pharmaceutical position peaked at $1.98M in Q2 2017.
302 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2017.

Based on Hutchin Hill Capital's 13F filing for Q3 2017, filed 14 Nov 2017.